Skip to main content
. 2016 Feb 14;7(16):21441–21453. doi: 10.18632/oncotarget.7375

Figure 1. MiR-329 was downregulated in the pancreatic cancer patients showing poor survival.

Figure 1

A. MiR-329 expression was investigated in the cancer tissue compared with its adjacent normal tissues of 34 patients by qPCR. Results are presented as log 2 fold change of cancer tissues relative to normal tissues. B. The average of miR-329 expression level in cancer and normal tissue of 34 patients were shown by bar graph. Data are shown 2−ΔΔCt values. C. MiR-329 expressions of pancreatic cancer cell lines SW1990, BXPC3 and ASPC1 compared with normal pancreatic ductal cell line HPDE were grafted by bar plots. D. The survival of pancreatic cancer patients were analyzed by Kaplan-Meier and log-rank tests. Patients were characterized by high and low expression of miR-329 based on the qPCR results shown in the panel A (high expression > 0; low expression < 0). Standard deviation of the mean was plotted for bar charts. (* P < 0.05, ** P < 0.01).